Guy Young, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Alnylam
    Topic:
    Hemophilia
    Date added:
    01/22/2026
    Date updated:
    01/22/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Biomarin
    Topic:
    Hemophilia
    Date added:
    01/22/2026
    Date updated:
    01/22/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    CSL
    Topic:
    Hemophilia
    Date added:
    01/22/2026
    Date updated:
    01/22/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Genentech
    Topic:
    Hemophilia
    Date added:
    01/22/2026
    Date updated:
    01/22/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Hema Biologics
    Topic:
    Hemophilia
    Date added:
    01/22/2026
    Date updated:
    01/22/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Hemab
    Topic:
    Hemophilia
    Date added:
    01/22/2026
    Date updated:
    01/22/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Novo Nordisk
    Topic:
    Hemophilia
    Date added:
    01/22/2026
    Date updated:
    01/22/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Octapharma
    Topic:
    Hemophilia
    Date added:
    01/22/2026
    Date updated:
    01/22/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Pfizer
    Topic:
    Hemophilia
    Date added:
    01/22/2026
    Date updated:
    01/22/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Sanofi
    Topic:
    Hemophilia
    Date added:
    01/22/2026
    Date updated:
    01/22/2026

Pages

Return to The Next Era in Non-Factor Therapy for Hemophilia: Clinical Evidence and Practical Implications of Evolving FVIIIA Mimetics